therapeutic_class,capsule_name,pdl_name,status
"INTERLEUKIN-13 (IL-13) INHIBITORS, MAB",Adbry Atopic Dermatitis (adult),ADBRY 150 MG/ML SYRINGE,Preferred
"INTERLEUKIN-13 (IL-13) INHIBITORS, MAB",Adbry Atopic Dermatitis (pediatric),ADBRY 150 MG/ML SYRINGE,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent Atopic Dermatitis (adult), pen",DUPIXENT 200 MG/1.14 ML PEN,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent Atopic Dermatitis (adult), prefilled syringe",DUPIXENT 100 MG/0.67 ML SYRING,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent pen, Asthma (adult)",DUPIXENT 200 MG/1.14 ML PEN,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent pen, Asthma (pediatric)",DUPIXENT 200 MG/1.14 ML PEN,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent pen, Atopic Dermatitis (pediatric)",DUPIXENT 200 MG/1.14 ML PEN,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent pen, Chronic Obstructive Pulmonary Disease (COPD)",DUPIXENT 200 MG/1.14 ML PEN,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent pen, Chronic Rhinosinusitis with Nasal Polyposis",DUPIXENT 200 MG/1.14 ML PEN,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent pen, Eosinophilic Esophagitis",DUPIXENT 200 MG/1.14 ML PEN,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent pen, Eosinophilic or Corticosteroid-Dependent Asthma",DUPIXENT 200 MG/1.14 ML PEN,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent pen, Prurigo Nodularis",DUPIXENT 200 MG/1.14 ML PEN,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent prefilled syringe, Asthma (adult)",DUPIXENT 100 MG/0.67 ML SYRING,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent prefilled syringe, Asthma (pediatric)",DUPIXENT 100 MG/0.67 ML SYRING,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent prefilled syringe, Atopic Dermatitis (pediatric)",DUPIXENT 100 MG/0.67 ML SYRING,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent prefilled syringe, Chronic Obstructive Pulmonary Disease (COPD)",DUPIXENT 100 MG/0.67 ML SYRING,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent prefilled syringe, Chronic Rhinosinusitis with Nasal Polyposis",DUPIXENT 100 MG/0.67 ML SYRING,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent prefilled syringe, Eosinophilic Esophagitis",DUPIXENT 100 MG/0.67 ML SYRING,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent prefilled syringe, Eosinophilic or Corticosteroid-Dependent Asthma",DUPIXENT 100 MG/0.67 ML SYRING,Preferred
"INTERLEUKIN-4(IL-4) RECEPTOR ALPHA ANTAGONIST, MAB","Dupixent prefilled syringe, Prurigo Nodularis",DUPIXENT 100 MG/0.67 ML SYRING,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Ankylosing Spondylitis, Mini cartridge",ENBREL 50 MG/ML MINI CARTRIDGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Ankylosing Spondylitis, SureClick",ENBREL 50 MG/ML SURECLICK,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Ankylosing Spondylitis, prefilled syringe",ENBREL 50 MG/ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Ankylosing Spondylitis, vial",ENBREL 25 MG/0.5 ML VIAL,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Plaque Psoriasis (adult), Mini cartridge",ENBREL 50 MG/ML MINI CARTRIDGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Plaque Psoriasis (adult), SureClick",ENBREL 50 MG/ML SURECLICK,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Plaque Psoriasis (adult), prefilled syringe",ENBREL 50 MG/ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Plaque Psoriasis (adult), vial",ENBREL 25 MG/0.5 ML VIAL,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Plaque Psoriasis (pediatric), Mini cartridge",ENBREL 50 MG/ML MINI CARTRIDGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Plaque Psoriasis (pediatric), SureClick",ENBREL 50 MG/ML SURECLICK,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Plaque Psoriasis (pediatric), prefilled syringe",ENBREL 50 MG/ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Plaque Psoriasis (pediatric), vial",ENBREL 25 MG/0.5 ML VIAL,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Polyarticular Juvenile Idiopathic Arthritis (PJIA), Mini cartridge",ENBREL 50 MG/ML MINI CARTRIDGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Polyarticular Juvenile Idiopathic Arthritis (PJIA), SureClick",ENBREL 50 MG/ML SURECLICK,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Polyarticular Juvenile Idiopathic Arthritis (PJIA), prefilled syringe",ENBREL 50 MG/ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Polyarticular Juvenile Idiopathic Arthritis (PJIA), vial",ENBREL 25 MG/0.5 ML VIAL,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Psoriatic Arthritis (adult), Mini cartridge",ENBREL 50 MG/ML MINI CARTRIDGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Psoriatic Arthritis (adult), SureClick",ENBREL 50 MG/ML SURECLICK,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Psoriatic Arthritis (adult), prefilled syringe",ENBREL 50 MG/ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Psoriatic Arthritis (adult), vial",ENBREL 25 MG/0.5 ML VIAL,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Rheumatoid Arthritis, Mini cartridge",ENBREL 50 MG/ML MINI CARTRIDGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Rheumatoid Arthritis, SureClick",ENBREL 50 MG/ML SURECLICK,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Rheumatoid Arthritis, prefilled syringe",ENBREL 50 MG/ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,"Enbrel Rheumatoid Arthritis, vial",ENBREL 25 MG/0.5 ML VIAL,Preferred
"TOP. ANTI-INFLAM.,PHOSPHODIESTERASE-4 (PDE4) INHIB",Eucrisa,EUCRISA 2% OINTMENT,Preferred
"INTERLEUKIN-5(IL-5) RECEPTOR ALPHA ANTAGONIST, MAB","Fasenra auto-injector, Asthma (adult)",FASENRA 10 MG/0.5 ML SYRINGE,Preferred
"INTERLEUKIN-5(IL-5) RECEPTOR ALPHA ANTAGONIST, MAB","Fasenra auto-injector, Asthma (pediatric)",FASENRA 30 MG/ML SYRINGE,Preferred
"INTERLEUKIN-5(IL-5) RECEPTOR ALPHA ANTAGONIST, MAB","Fasenra auto-injector, Eosinophilic Granulomatosis with Polyangitis (EGPA)",FASENRA PEN 30 MG/ML,Preferred
"INTERLEUKIN-5(IL-5) RECEPTOR ALPHA ANTAGONIST, MAB","Fasenra prefilled syringe, Asthma (adult)",FASENRA 30 MG/ML SYRINGE,Preferred
"INTERLEUKIN-5(IL-5) RECEPTOR ALPHA ANTAGONIST, MAB","Fasenra prefilled syringe, Asthma (pediatric)",FASENRA 30 MG/ML SYRINGE,Preferred
"INTERLEUKIN-5(IL-5) RECEPTOR ALPHA ANTAGONIST, MAB","Fasenra prefilled syringe, Eosinophilic Granulomatosis with Polyangitis (EGPA)",FASENRA 30 MG/ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Hadlima Ankylosing Spondylitis,HADLIMA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Hadlima Crohn’s Disease (adult),HADLIMA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Hadlima Crohn’s Disease (pediatric),HADLIMA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Hadlima Hidradenitis Suppurativa,HADLIMA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Hadlima Plaque Psoriasis (adult),HADLIMA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Hadlima Polyarticular Juvenile Idiopathic Arthritis (PJIA),HADLIMA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Hadlima Psoriatic Arthritis (adult),HADLIMA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Hadlima Rheumatoid Arthritis,HADLIMA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Hadlima Ulcerative Colitis (adult),HADLIMA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Hadlima Uveitis (adult),HADLIMA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Ankylosing Spondylitis,HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Crohn's Disease (adult),HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Crohn's Disease (pediatric),HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Hidradenitis Suppurativa,HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Plaque Psoriasis (adult),HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Polyarticular Juvenile Idiopathic Arthritis (PJIA),HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Psoriatic Arthritis (adult),HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Rheumatoid Arthritis,HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Ulcerative Colitis (adult),HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Ulcerative Colitis (pediatric),HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Uveitis (adult),HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
ANTI-INFLAMMATORY TUMOR NECROSIS FACTOR INHIBITOR,Humira Uveitis (pediatric),HUMIRA 40 MG/0.8 ML SYRINGE,Preferred
"ANTI-INFLAMMATORY,PHOSPHODIESTERASE-4(PDE4) INHIB.","Otezla Behcet’s Disease, 30 mg",OTEZLA 30 MG TABLET,Preferred
"ANTI-INFLAMMATORY,PHOSPHODIESTERASE-4(PDE4) INHIB.","Otezla Behcet’s Disease, starter pack",OTEZLA 10-20 MG STARTER 28 DAY,Preferred
"ANTI-INFLAMMATORY,PHOSPHODIESTERASE-4(PDE4) INHIB.","Otezla Plaque Psoriasis (adult), 30 mg",OTEZLA 30 MG TABLET,Preferred
"ANTI-INFLAMMATORY,PHOSPHODIESTERASE-4(PDE4) INHIB.","Otezla Plaque Psoriasis (adult), starter pack",OTEZLA 10-20 MG STARTER 28 DAY,Preferred
"ANTI-INFLAMMATORY,PHOSPHODIESTERASE-4(PDE4) INHIB.","Otezla Plaque Psoriasis (pediatric), 30 mg",OTEZLA 30 MG TABLET,Preferred
"ANTI-INFLAMMATORY,PHOSPHODIESTERASE-4(PDE4) INHIB.","Otezla Plaque Psoriasis (pediatric), starter pack",OTEZLA 10-20 MG STARTER 28 DAY,Preferred
"ANTI-INFLAMMATORY,PHOSPHODIESTERASE-4(PDE4) INHIB.","Otezla Psoriatic Arthritis (adult), 30 mg",OTEZLA 30 MG TABLET,Preferred
"ANTI-INFLAMMATORY,PHOSPHODIESTERASE-4(PDE4) INHIB.","Otezla Psoriatic Arthritis (adult), starter pack",OTEZLA 10-20 MG STARTER 28 DAY,Preferred
JANUS KINASE (JAK) INHIBITORS,"Rinvoq Ankylosing Spondylitis, ER tablet",RINVOQ ER 15 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Rinvoq Atopic Dermatitis (adult), ER tablet",RINVOQ ER 15 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Rinvoq Crohn's Disease (adult), ER tablet",RINVOQ ER 15 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Rinvoq Non-Radiographic Axial Spondyloarthritis, ER tablet",RINVOQ ER 15 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Rinvoq Polyarticular Juvenile Idiopathic Arthritis (PJIA), ER tablet",RINVOQ ER 15 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Rinvoq Polyarticular Juvenile Idiopathic Arthritis (PJIA), LQ",RINVOQ LQ 1 MG/ML SOLUTION,Preferred
JANUS KINASE (JAK) INHIBITORS,"Rinvoq Psoriatic Arthritis (adult), ER tablet",RINVOQ ER 15 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Rinvoq Psoriatic Arthritis (pediatric), ER tablet",RINVOQ ER 15 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Rinvoq Psoriatic Arthritis (pediatric), LQ",RINVOQ LQ 1 MG/ML SOLUTION,Preferred
JANUS KINASE (JAK) INHIBITORS,"Rinvoq Rheumatoid Arthritis, ER tablet",RINVOQ ER 15 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Rinvoq Ulcerative Colitis (adult), ER tablet",RINVOQ ER 15 MG TABLET,Preferred
THYMIC STROMAL LYMPHOPOIETIN (TSLP) INHIBITORS,"Tezspire auto-injector, Asthma (adult)",TEZSPIRE 210 MG/1.91 ML PEN,Preferred
THYMIC STROMAL LYMPHOPOIETIN (TSLP) INHIBITORS,"Tezspire prefilled syringe, Asthma (adult)",TEZSPIRE 210 MG/1.91 ML SYRING,Preferred
JANUS KINASE (JAK) INHIBITORS,"Xeljanz Ankylosing Spondylitis, 10 mg, IR tablet",XELJANZ 10 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Xeljanz Ankylosing Spondylitis, 5 mg, IR tablet",XELJANZ 5 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Xeljanz Polyarticular Juvenile Idiopathic Arthritis (PJIA), 10 mg, IR tablet",XELJANZ 10 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Xeljanz Polyarticular Juvenile Idiopathic Arthritis (PJIA), 5 mg, IR tablet",XELJANZ 5 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Xeljanz Psoriatic Arthritis (adult), 10 mg, IR tablet",XELJANZ 10 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Xeljanz Psoriatic Arthritis (adult), 5 mg, IR tablet",XELJANZ 5 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Xeljanz Rheumatoid Arthritis, 10 mg, IR tablet",XELJANZ 10 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Xeljanz Rheumatoid Arthritis, 5 mg, IR tablet",XELJANZ 5 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Xeljanz Ulcerative Colitis (adult), 10 mg, IR tablet",XELJANZ 10 MG TABLET,Preferred
JANUS KINASE (JAK) INHIBITORS,"Xeljanz Ulcerative Colitis (adult), 5 mg, IR tablet",XELJANZ 5 MG TABLET,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair auto-injector, Asthma (adult)",XOLAIR 150 MG/ML AUTOINJECTOR,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair auto-injector, Asthma (pediatric)",XOLAIR 150 MG/ML AUTOINJECTOR,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair auto-injector, Chronic Rhinosinusitis with Nasal Polyposis",XOLAIR 150 MG/ML AUTOINJECTOR,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair auto-injector, Chronic Spontaneous Urticaria (CSU)",XOLAIR 150 MG/ML AUTOINJECTOR,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair auto-injector, IgE-Mediated Food Allergy",XOLAIR 150 MG/ML AUTOINJECTOR,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair prefilled syringe, Asthma (adult)",XOLAIR 150 MG/ML SYRINGE,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair prefilled syringe, Asthma (pediatric)",XOLAIR 150 MG/ML SYRINGE,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair prefilled syringe, Chronic Rhinosinusitis with Nasal Polyposis",XOLAIR 150 MG/ML SYRINGE,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair prefilled syringe, Chronic Spontaneous Urticaria (CSU)",XOLAIR 150 MG/ML SYRINGE,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair prefilled syringe, IgE-Mediated Food Allergy",XOLAIR 150 MG/ML SYRINGE,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair vial, Asthma (adult)",XOLAIR 150 MG/ML SYRINGE,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair vial, Asthma (pediatric)",XOLAIR 150 MG/ML SYRINGE,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair vial, Chronic Rhinosinusitis with Nasal Polyposis",XOLAIR 150 MG/ML SYRINGE,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair vial, Chronic Spontaneous Urticaria (CSU)",XOLAIR 150 MG/ML SYRINGE,Preferred
MONOCLONAL ANTIBODIES TO IMMUNOGLOBULIN E (IGE),"Xolair vial, IgE-Mediated Food Allergy",XOLAIR 150 MG/ML SYRINGE,Preferred
